Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.58 USD | +2.13% | -0.21% | -14.77% |
05-13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
05-13 | Earnings Flash (TBPH) THERAVANCE BIOPHARMA Posts Q1 Revenue $14.5M, vs. Street Est of $14M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.77% | 455M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Theravance Biopharma : Needham Adjusts Theravance Biopharma's Price Target to $18 From $32, Keeps Buy Rating